Hepatic Endometriosis and Hemoperitoneum Understanding Deep Endometriosis, Diagnosis, and Treatment
Endometriosis is usually discussed as a pelvic disease, yet its biology is not confined to the pelvis. Ectopic endometrial tissue has been described in the bowel, bladder, diaphragm, pleura, surgical scars, and, in rare cases, the liver. When hepatic lesions bleed or rupture, the presentation can shift from diagnostic uncertainty to a surgical emergency.
Hepatic endometriosis is uncommon enough that many clinicians may never encounter a confirmed case. Still, it matters because it can mimic hepatic tumours, abscesses, hydatid cysts, or haemorrhagic cystic lesions. It may also present with acute haemoperitoneum, particularly when a subcapsular lesion ruptures.
This article is for medical education only and does not replace specialist clinical judgement, local protocols, or multidisciplinary decision-making.
What hepatic endometriosis means and how often it occurs
Hepatic endometriosis refers to the presence of functional endometrial-type glands and stroma within the liver parenchyma, on the hepatic capsule, or in a subcapsular location. Like pelvic endometriosis, these implants may respond to cyclical hormonal changes. They can undergo repeated bleeding, fibrosis, inflammation, and cystic degeneration.
The condition is exceptionally rare. Most knowledge comes from isolated case reports and small case series rather than population-level data. For that reason, true prevalence remains unknown. It is far less common than ovarian endometriomas, bowel involvement, urinary tract endometriosis, or diaphragmatic disease.
Reported hepatic lesions have appeared in several patterns:
Subcapsular cystic lesions, often in the right hepatic lobe
Intraparenchymal cyst-like masses with haemorrhagic contents
Capsular implants associated with diaphragmatic or peritoneal disease
Lesions discovered incidentally during imaging or surgery for other endometriosis symptoms
The rarity creates a diagnostic challenge. A hepatic mass in a reproductive-age patient with cyclical right upper quadrant pain may not immediately raise suspicion for HEPATIC ENDOMETRIOSIS. Yet in the right clinical context, including known severe endometriosis, previous pelvic surgery, infertility evaluation, or catamenial symptoms, it should enter the differential.
Why the liver can be involved in endometriosis
No single theory explains all extra-pelvic endometriosis. Hepatic involvement is likely multifactorial.
The main proposed mechanisms include:
Transcoelomic spread
Retrograde menstruation may seed endometrial cells into the peritoneal cavity. Peritoneal fluid circulation can carry cells to upper abdominal surfaces, especially the right hemidiaphragm and subhepatic region. This may explain why right-sided diaphragmatic, pleural, and hepatic capsular disease are often discussed together.
Lymphatic or haematogenous dissemination
Endometrial cells may spread through lymphatic or blood vessels. This theory is often invoked for distant sites that are difficult to explain by direct peritoneal flow alone.
Coelomic metaplasia
Peritoneal or submesothelial cells may transform into endometrial-type tissue under inflammatory, hormonal, or genetic influences. This may help explain unusual locations and disease in patients without obvious pelvic continuity.
Iatrogenic implantation
Prior surgery can contribute to endometriosis in scars or abdominal wall sites. For hepatic disease, direct implantation is less straightforward, but previous pelvic or abdominal procedures may still form part of the clinical background.
These mechanisms are not mutually exclusive. Advanced endometriosis often behaves as a systemic inflammatory disease with local invasion, angiogenesis, fibrosis, and altered immune clearance.
How hepatic endometriosis can lead to haemoperitoneum
Haemoperitoneum occurs when blood accumulates in the peritoneal cavity. In hepatic endometriosis, this may happen when an endometriotic hepatic lesion bleeds into the peritoneal space.
The proposed pathways include:
Recurrent cyclical haemorrhage within an endometriotic cyst
Progressive rise in intracystic pressure
Capsular thinning and rupture in subcapsular lesions
Tearing of adhesions between the liver, diaphragm, and peritoneum
Invasion or irritation of small vessels within or around the lesion
A patient may present with sudden-onset abdominal pain, shoulder-tip pain, syncope, tachycardia, hypotension, or signs of peritonism. The timing may coincide with menstruation, but absence of clear cyclicity does not exclude the diagnosis.
In many acute cases, the first priority is not to prove endometriosis. It is to identify active bleeding, stabilise the patient, and control haemorrhage.
Clinical features that should raise suspicion
Hepatic involvement may present with non-specific symptoms, which can delay recognition. Suspicion increases when the following features cluster together:
Recurrent right upper quadrant or epigastric pain
Catamenial worsening of pain
Known moderate to severe endometriosis
Prior ovarian endometrioma or deep endometriosis
Imaging showing a haemorrhagic hepatic cystic lesion
Free intraperitoneal fluid without a clear gynaecological source
Normal or only mildly altered liver function tests despite symptoms
Some patients remain asymptomatic until imaging detects a lesion. Others present dramatically with acute abdomen and haemodynamic compromise.
The relationship between deep endometriosis and hepatic disease
Deep endometriosis generally refers to endometriotic lesions infiltrating more than 5 mm beneath the peritoneal surface. It commonly involves the uterosacral ligaments, rectovaginal septum, bowel, bladder, ureters, and pelvic sidewall. It is strongly associated with fibrosis, adhesions, anatomic distortion, and chronic pain.
The link between deep endometriosis and hepatic involvement is not fully defined, but there are plausible clinical associations.
Deep disease often reflects a more invasive and inflammatory phenotype. Patients with extensive pelvic adhesions, ovarian endometriomas, diaphragmatic implants, or thoracic symptoms may have a higher probability of extra-pelvic disease than patients with superficial peritoneal implants alone.
Hepatic lesions may also sit within a broader pattern of upper abdominal endometriosis. The right hemidiaphragm, hepatic capsule, and subhepatic space are anatomically close. Peritoneal fluid movement tends to favour the right upper abdomen, partly due to the falciform ligament and right paracolic gutter flow patterns. This may help explain why right-sided upper abdominal disease appears more often in case descriptions.
A careful preoperative assessment for deep endometriosis is useful when hepatic disease is suspected. It helps the team plan whether the operation should involve gynaecologic surgeons, hepatobiliary surgeons, colorectal surgeons, urologists, or interventional radiologists.
Representative clinical examples from reported patterns
Because hepatic endometriosis is rare, individual reports shape much of the clinical understanding. The following examples are representative patterns, not patient-specific records.
A cyclical pain presentation that mimics a hepatic cyst
A reproductive-age patient with known pelvic endometriosis develops recurrent right upper quadrant pain, worse around menstruation. Liver function tests are normal. Ultrasound identifies a cystic lesion near the hepatic capsule. CT suggests a complex cyst, while MRI shows haemorrhagic content.
At laparoscopy, the team finds pelvic adhesions, endometriotic implants, and a subcapsular hepatic lesion. Excision or deroofing is performed with hepatobiliary support. Histology confirms endometrial glands and stroma with haemorrhage and haemosiderin-laden macrophages.
This pattern highlights how hormonal cyclicity and MRI characteristics can shift suspicion towards endometriosis.
An acute haemoperitoneum presentation
A patient presents to emergency care with sudden severe abdominal pain, pallor, tachycardia, and falling haemoglobin. Pregnancy test is negative. Imaging shows free intraperitoneal fluid and a haemorrhagic lesion at the liver surface. No ruptured ectopic pregnancy or ovarian cyst is found.
Surgical exploration reveals haemoperitoneum and bleeding from a ruptured subcapsular hepatic cystic lesion. Haemostasis is achieved. The lesion is excised or sampled, and pathology later confirms endometriosis.
This pattern is clinically important because the diagnosis may be retrospective. The acute priority is resuscitation and bleeding control.
A deep endometriosis case with upper abdominal extension
A patient undergoing evaluation for severe dysmenorrhoea, dyspareunia, dyschezia, and suspected bowel involvement has MRI evidence of deep pelvic endometriosis. During staging or surgery, diaphragmatic implants and adhesions near the liver are noted. A small hepatic capsular lesion is identified and sampled.
Histology confirms endometriosis involving the hepatic capsule. This pattern supports the concept that hepatic disease can form part of extensive deep and extra-pelvic endometriosis.
Diagnostic methods clinicians use
Diagnosis relies on correlation between symptoms, imaging, operative findings, and histopathology. No single clinical feature is definitive.
Imaging assessment
Ultrasound
Ultrasound may detect a hepatic cystic or complex lesion, but findings are often non-specific. It is useful as an initial test, especially in acute abdominal pain or for follow-up of known lesions.
CT
CT can identify haemoperitoneum, active bleeding, hepatic masses, and alternative diagnoses. In emergency settings, contrast-enhanced CT helps assess haemodynamic risk and surgical planning.
MRI
MRI is usually the most informative modality for characterising blood products. T1 hyperintensity, shading, fluid-fluid levels, and features of chronic haemorrhage may resemble endometriomas elsewhere. MRI can also assess pelvic deep endometriosis in the same diagnostic pathway.
Laboratory testing
Laboratory results are supportive rather than diagnostic.
Possible findings include:
Anaemia in acute or recurrent bleeding
Normal or mildly abnormal liver enzymes
Raised inflammatory markers if irritation or infection is suspected
CA-125 elevation in some patients, although this is non-specific
A pregnancy test remains essential in acute haemoperitoneum among patients of reproductive potential.
Histopathology and immunohistochemistry
Definitive diagnosis requires identification of endometrial-type glands and stroma. Histology may show old haemorrhage, fibrosis, and haemosiderin.
Immunohistochemistry can support the diagnosis. Endometrial stromal cells often express CD10, while oestrogen and progesterone receptor positivity may also be present.
Biopsy decisions require care. In a vascular or haemorrhagic lesion, percutaneous biopsy may carry bleeding risk and may not be the best first step. The decision should depend on imaging, stability, malignancy risk, and whether tissue diagnosis will alter management.
Key differential diagnoses
Hepatic endometriosis can resemble several conditions:
Differential diagnosis | Why it may appear similar |
Haemorrhagic hepatic cyst | Cystic lesion with blood products |
Hepatic adenoma | May bleed, particularly in hormone-sensitive contexts |
Haemangioma | Common vascular lesion, sometimes atypical on imaging |
Hydatid cyst | Cystic hepatic lesion, relevant in endemic regions |
Abscess | Complex lesion with pain and inflammatory markers |
Biliary cystadenoma or cystadenocarcinoma | Multiloculated cystic hepatic mass |
Metastatic disease | Complex mass requiring exclusion in selected patients |
Hepatocellular carcinoma | Considered when risk factors or imaging features support it |
Treatment options and multidisciplinary care
Treatment depends on symptoms, lesion size and location, bleeding risk, fertility goals, disease extent, and patient stability.
Acute haemoperitoneum management
Acute bleeding requires standard emergency priorities:
Haemodynamic assessment and resuscitation
Blood tests including full blood count, coagulation profile, group and crossmatch
Pregnancy testing where relevant
Contrast imaging if the patient is stable enough
Early involvement of surgery, gynaecology, hepatobiliary surgery, anaesthesia, and interventional radiology
Management may include laparoscopy, laparotomy, hepatic packing, cautery, suturing, resection, or radiological embolisation in selected cases. The approach depends on the bleeding source and local expertise.
Medical treatment
Hormonal suppression may reduce cyclical stimulation of endometriotic tissue. Options include combined hormonal contraceptives, progestins, gonadotropin-releasing hormone agonists or antagonists, and other endometriosis-directed regimens.
Medical therapy may suit small, stable lesions or postoperative suppression. It is less appropriate as sole treatment when malignancy cannot be excluded, symptoms are severe, or there is active bleeding.
Surgical treatment
Surgery may be indicated for symptomatic lesions, diagnostic uncertainty, rupture risk, acute haemorrhage, or failure of medical therapy.
Options include:
Laparoscopic excision of capsular disease
Cyst excision or deroofing in selected cases
Segmental hepatic resection for deeper or suspicious lesions
Simultaneous treatment of pelvic, bowel, diaphragmatic, or urinary tract endometriosis
The surgical plan should account for the whole disease map. Treating a hepatic lesion while missing severe pelvic or diaphragmatic disease may lead to persistent symptoms.
The practical takeaway
Hepatic endometriosis is rare, but its complications can be serious. A haemorrhagic hepatic lesion in a patient with known deep endometriosis, cyclical upper abdominal pain, or unexplained haemoperitoneum deserves careful evaluation.
The strongest approach is multidisciplinary. MRI can help characterise haemorrhagic lesions and map deep disease. CT is valuable in acute bleeding. Histology confirms the diagnosis. Treatment ranges from hormonal suppression to urgent operative or interventional control of haemorrhage.
For clinicians, the key is not to overdiagnose every hepatic cyst as endometriosis. It is to recognise the pattern when the history, imaging, operative findings, and disease biology point in the same direction.
Comments